Before joining UCLA, Charles Grob held faculty positions at The Johns Hopkins University School of Medicine and the University of California, Irvine. He has conducted approved clinical research with psychedelics since the early 1990s. From 2004-2008, he was the principal investigator of the first study in several decades to FUNDING OPPORTUNITY FOR THE UCLA PSYCHEDELIC STUDIES INITIATIVE 6 examine the use of a psilocybin treatment model for patients with advanced cancer anxiety. He also has conducted research into the range of effects of MDMA, in both normal volunteers and in a selected subject population of adult autistics with severe social anxiety. Charles has conducted a series of ayahuasca research studies in Brazil. Over the last 30 years, he has authored numerous published articles and chapters on psychedelics in medical and psychiatric literature. He is the editor of Hallucinogens: A Reader, co-editor (with Roger Walsh, M.D., Ph.D.) of Higher Wisdom: Eminent Elders Explore the Continuing Impact of Psychedelics, and co-editor (with James Grigsby, Ph.D.) of the Handbook of Medical Hallucinogens, published in 2021. Charles is a founding board member of the Heffter Research Institute.